Thu, Apr 17, 2014, 5:54 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

OncoGenex Pharmaceuticals, Inc. Message Board

  • marsfilander marsfilander May 23, 2013 10:31 AM Flag

    New trial (Cedar) for 427

    This will be the seventh Phase II trial for 427 ("Cedar™ clinical trial, an investigator-sponsored, randomized, open-label Phase 2 trial evaluating OGX-427 in previously untreated patients with advanced squamous cell lung cancer") .
    Based on some of the posts from this very helpful message board (summer, kuvaz, sssamsa, box) and the company's own releases, I know we're in for a wait until 2014. But, it surely seems a good sign that they have enough confidence in 427 to launch so many trials. Also, if indeed the recent selloff was Fidelity (and who knows why, could be unrelated to anything with this particular stock) it seems we should be on a path upward now in terms of pps. What are others' thoughts?
    I'm looking forward to ASCO and staying with this one for the long haul.

    Sentiment: Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • News cycle is in 2014 but as others have commented we should see a run starting 2H/13 as we move closer to these transformation trial events. I expect a major move in PPS and want to be positioned to take capital gains on my trading shares not ordinary income.

 
OGXI
10.32+0.07(+0.68%)Apr 17 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.